Trials / NCT01531348
Intravitreal Injection of MSCs in Retinitis Pigmentosa
Completed Phase 1 Cell therapy
- Sponsor
- Mahidol University
- Treatment
- BM-MSC
- Gene
- Not stated
- Conditions
- Retinitis Pigmentosa
- Ages
- 18 Years to 65 Years
- Enrollment
- 14 participants
- Started
- 2012-04
- Main results expected
- 2020-07
- Results posted
- Not yet
- Record last updated
- 2021-09-08
What the study is testing
The purpose of this study is to determine the feasibility and safety of adult human bone marrow-derived mesenchymal stem cells by intravitreal injection in patients with retinitis pigmentosa.
Where it runs
Thailand (1)
- Siriraj Hospital Mahidol University, Bangkoknoi, Bangkok